New Balloon Guide Catheter for Acute Ischemic Stroke Treatment

 A next generation balloon guide catheter (Emboguard; CERENOVUS, Irvine, CA) to be used in endovascular procedures for individuals with acute ischemic stroke, has become available. The balloon guide catheters increase first pass recanalization, reduce procedure time, and reduce the odds of clot fragments breaking off and causing distal emboli.

The balloon guide catheter is designed to optimize removal of clots by controlling blood flow locally during mechanical thrombectomy (MT) procedures. The balloon guide catheters will debut for the first time at the International Stroke Conference in New Orleans, Louisiana from February 9-11, 2022.
 
“Without timely and effective treatment of stroke, patients can suffer from lifelong disability or dependency,” said David Fiorella MD, PhD, director of Cerebrovascular Center, Stony Brook University Hospital. “The benefits of balloon guide catheters are becoming increasingly recognized for their ability to maximize patient outcomes. By adding this innovation to their Stroke Solutions portfolio, CERENOVUS will be arming physicians with the tools they need to better serve our patients, potentially increasing the chances to live a functional and fulfilling life post-stroke.”
  
“We’re proud to announce the addition of Emboguard into our family of CERENOVUS Stroke Solutions,” said Mark Dickinson, Worldwide president, CERENOVUS. “The addition of this device to our portfolio of technologies provides physicians with an innovative and comprehensive set of tools to treat their patients, building on our commitment to changing the trajectory of stroke.”